These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 36082872)
1. The Resilience of Juárez-López D; Morales-Ruiz E; Herrera-Zúñiga LD; González-Carrera Z; Cuevas-Reyes E; Corzo G; Schcolnik-Cabrera A; Villegas E Curr Med Chem; 2022; 30(1):72-103. PubMed ID: 36082872 [TBL] [Abstract][Full Text] [Related]
2. Van Moll L; De Smet J; Paas A; Tegtmeier D; Vilcinskas A; Cos P; Van Campenhout L Microbiol Spectr; 2022 Feb; 10(1):e0166421. PubMed ID: 34985302 [TBL] [Abstract][Full Text] [Related]
3. The Mechanism of Killing by the Proline-Rich Peptide Bac7(1-35) against Clinical Strains of Pseudomonas aeruginosa Differs from That against Other Gram-Negative Bacteria. Runti G; Benincasa M; Giuffrida G; Devescovi G; Venturi V; Gennaro R; Scocchi M Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137800 [No Abstract] [Full Text] [Related]
4. The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is severely constrained by random peptide mixtures. Antunes B; Zanchi C; Johnston PR; Maron B; Witzany C; Regoes RR; Hayouka Z; Rolff J PLoS Biol; 2024 Jul; 22(7):e3002692. PubMed ID: 38954678 [TBL] [Abstract][Full Text] [Related]
5. A Foundation Model Identifies Broad-Spectrum Antimicrobial Peptides against Drug-Resistant Bacterial Infection. Li T; Ren X; Luo X; Wang Z; Li Z; Luo X; Shen J; Li Y; Yuan D; Nussinov R; Zeng X; Shi J; Cheng F Nat Commun; 2024 Aug; 15(1):7538. PubMed ID: 39214978 [TBL] [Abstract][Full Text] [Related]
6. An in-vivo experimental evaluation of the efficacy of fish-derived antimicrobial peptides against multidrug-resistant Al-Rasheed AA; Garba B; Handool KO; Al-Jashamy KA; Odhah MNA; Dirie NI; Daud HM Pan Afr Med J; 2023; 46():112. PubMed ID: 38465008 [TBL] [Abstract][Full Text] [Related]
7. 'Targeting' the search: An upgraded structural and functional repository of antimicrobial peptides for biofilm studies (B-AMP v2.0) with a focus on biofilm protein targets. Ravichandran S; Avatapalli S; Narasimhan Y; Kaushik KS; Yennamalli RM Front Cell Infect Microbiol; 2022; 12():1020391. PubMed ID: 36329825 [TBL] [Abstract][Full Text] [Related]
8. In silico design of polycationic antimicrobial peptides active against Pseudomonas aeruginosa and Staphylococcus aureus. Hincapié O; Giraldo P; Orduz S Antonie Van Leeuwenhoek; 2018 Oct; 111(10):1871-1882. PubMed ID: 29626331 [TBL] [Abstract][Full Text] [Related]
9. Intelligent De Novo Design of Novel Antimicrobial Peptides against Antibiotic-Resistant Bacteria Strains. Lin TT; Yang LY; Lin CY; Wang CT; Lai CW; Ko CF; Shih YH; Chen SH Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047760 [TBL] [Abstract][Full Text] [Related]
10. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance? Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762 [TBL] [Abstract][Full Text] [Related]
11. In Silico-Based Design of a Hybrid Peptide with Antimicrobial Activity against Multidrug-Resistant Shin MK; Park HR; Hwang IW; Bu KB; Jang BY; Lee SH; Oh JW; Yoo JS; Sung JS Toxins (Basel); 2023 Nov; 15(12):. PubMed ID: 38133172 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial Activity and Stability of Short and Long Based Arachnid Synthetic Peptides in the Presence of Commercial Antibiotics. Arenas I; Villegas E; Walls O; Barrios H; Rodríguez R; Corzo G Molecules; 2016 Feb; 21(2):. PubMed ID: 26901176 [TBL] [Abstract][Full Text] [Related]
13. The Remarkable Innate Resistance of Burkholderia bacteria to Cationic Antimicrobial Peptides: Insights into the Mechanism of AMP Resistance. Ghimire J; Guha S; Nelson BJ; Morici LA; Wimley WC J Membr Biol; 2022 Oct; 255(4-5):503-511. PubMed ID: 35435452 [TBL] [Abstract][Full Text] [Related]
14. Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins. Hashemi MM; Rovig J; Weber S; Hilton B; Forouzan MM; Savage PB Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584137 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial properties of membrane-active dodecapeptides derived from MSI-78. Monteiro C; Fernandes M; Pinheiro M; Maia S; Seabra CL; Ferreira-da-Silva F; Costa F; Reis S; Gomes P; Martins MC Biochim Biophys Acta; 2015 May; 1848(5):1139-46. PubMed ID: 25680229 [TBL] [Abstract][Full Text] [Related]
16. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens. Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481 [TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria. Wu X; Li Z; Li X; Tian Y; Fan Y; Yu C; Zhou B; Liu Y; Xiang R; Yang L Drug Des Devel Ther; 2017; 11():939-946. PubMed ID: 28356719 [TBL] [Abstract][Full Text] [Related]